News & Analysis on Clinical Trial Services & Contract Research And Development
Do-Coop Technologies, an Israeli company that uses nanotechnology to create an equivalent of intracellular water as a medium for enhancing existing chemical and biological reagents, reactions and processes, has announced two "significant milestones"...
A first-in-class drug developed to battle high blood pressure might not be the blockbuster success Novartis hoped for after a new study claims it is no more effective than current therapies.
Clariant has cut its ties with the life sciences industry and will no longer offer custom manufacturing services in this arena after the sale of the last piece of its Lifesciences division.
A new human vaccine to be used in the case of a flu pandemic has gained approval in the EU. The Novartis vaccine, Focetria, will be manufactured containing the offending virus should the World Health Organization's warning system rise to a level 6...
The UK's Midatech Group has opened what it describes as "the world's first cGMP-grade manufacturing plant for the production of nanoparticles at a scale commensurate with pharmaceutical applications".
Pfizer is trying to be more transparent by making information on the status of its US post-marketing (Phase IV) drug studies accessible to the public.
As single-use technologies become more and more popular for use in biopharmaceutical manufacturing, Pall is following market demands bolstering its product line by adding a number of disposable products to its portfolio.